Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Last revision Both sides next revision
mig [2018/11/18 11:35]
sflitman [Migraine]
mig [2018/11/18 11:36]
sflitman [Migraine]
Line 5: Line 5:
 ^ Condition(s) ​ ^ Type of Drug  ^  Phase  ^  Add-On ​ ^  Placebo ​ ^  Duration ​ ^  Open-Label Extension ​ ^  ^ Condition(s) ​ ^ Type of Drug  ^  Phase  ^  Add-On ​ ^  Placebo ​ ^  Duration ​ ^  Open-Label Extension ​ ^
 | Treatment-resistant migraine prevention | Approved drug Emgality |  III  |  Yes  |  50%  |  3 months ​ |  3 months ​ | | Treatment-resistant migraine prevention | Approved drug Emgality |  III  |  Yes  |  50%  |  3 months ​ |  3 months ​ |
-| Abortive therapy for acute migraine | Combination ​of two approved drugs |  III  |  Yes  |  33%  |  12 weeks  |  None  |+| Abortive therapy for acute migraine | Oral combination ​of two approved drugs |  III  |  Yes  |  33%  |  12 weeks  |  None  |
  
 <​html><​!-- <​html><​!--
Print/export
QR Code
QR Code mig (generated for current page)